Research menu
Jump to menu

Publications:  Dr Ajay Gupta

Gupta AK, Jneid H, Addison D, Ardehali H, Boehme AK, Borgaonkar S, Boulestreau R, Clerkin K et al.(2020). Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors. J Am Heart Assoce017013-e017013.
Kapil V, Gupta AK(2020). Solar UV Radiation: A Potential Modifiable Risk Factor for Hypertension. Journal of the American Heart Association vol. 9, (5) e015627-e015627.
Berkelmans GFN, Gudbjörnsdottir S, Visseren FLJ, Wild SH, Franzen S, Chalmers J, Davis BR, Poulter NR et al.(2019). Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus. European Heart Journal vol. 40, (34) 2899-2906.
Cabrera CP, Ng F, Nicholls HL, Gupta A, Barnes MR, Munroe PB, Caulfield MJ(2019). Over 1000 genetic loci influencing blood pressure with multiple systems and tissues implicated. Human Molecular Genetics vol. 28, (R2) R151-R161.
Maniero C, Gupta A, Lobo MD(2019). Impact of the new acc/aha and esc/ESH hypertension guidelines in the UK. European Heart Journal vol. 40, (30) 2472-2475.
Rahimi K, Canoy D, Nazarzadeh M, Salimi-Khorshidi G, Woodward M, Teo K, Davis BR, Chalmers J et al.(2019). Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC). BMJ Open vol. 9, (5) e028698-e028698.
Poulter NR, Dolan E, Gupta AK, O'Brien E, Whitehouse A, Sever PS(2019). Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension. Am J Cardiovasc Drugs
Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P(2018). Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial. The Lancet vol. 392, (10153) 1127-1137.
Saxena M, Shour T, Shah M, Wolff CB, Julu POO, Kapil V, Collier DJ, Ng FL et al.(2018). Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success. J Am Heart Assoc vol. 7, (12)
Gupta AK(2018). Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention. Journal of the American Heart Association vol. 7, (10) e009648-e009648.
McGlone ER, Gupta AK, Reddy M, Khan OA(2018). Antral resection versus antral preservation during laparoscopic sleeve gastrectomy for severe obesity: Systematic review and meta-analysis. Surg Obes Relat Dis
Gupta A, Godec T, Sever P(2017). Concerns related to the nocebo effect - Authors’ reply. Lancet vol. 390, Article 10105, 1832-1832.
Marcano-Belisario JS, Gupta AK, O Donoghue J, Ramchandani P, Morrison C, Car J(2017). Implementation of depression screening in antenatal clinics through tablet computers: results of a feasibility study. BMC Med Inform Decis Mak vol. 17, Article 1, 59-59.
Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, Collins R, Sever P(2017). Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet vol. 389, Article 10088, 2473-2481.
Stam-Slob MC, Visseren FL, Wouter Jukema J, van der Graaf Y, Poulter NR, Gupta A, Sattar N, Macfarlane PW et al.(2016). Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Clin Res Cardiol vol. 106, Article 1, 58-68.
Marcano-Belisario JS, Gupta AK, O Donoghue J, Morrison C, Car J(2016). Tablet computers for implementing NICE antenatal mental health guidelines: protocol of a feasibility study. BMJ Open vol. 6, Article 1, e009930-e009930.
Prieto-Merino D, Dobson J, Gupta AK, Chang CL, Sever PS, Dahlof B, Wedel H, Pocock S et al.(2013). ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data. J Hum Hypertens vol. 27, Article 8, 492-6.
Kelishadi R, de Ferranti SD, Majdzadeh R, O Dea JA, Gupta AK, Adeli K(2013). Childhood obesity: today and tomorrow’s health challenge. J Obes vol. 2013, 208392-208392.
Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML et al.(2013). Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. Jama vol. 310, Article 9, 918-29.
Kelishadi R, Amin MM, Haghdoost AA, Gupta AK, Tuhkanen TA(2013). Pollutants source control and health effects. J Environ Public Health vol. 2013, 209739-209739.
Sever PS, Chang CL, Prescott MF, Gupta A, Poulter NR, Whitehouse A, Scanlon M(2012). Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Eur Heart J vol. 33, Article 23, 2970-9.
Elley CR, Gupta AK, Webster R, Selak V, Jun M, Patel A, Rodgers A, Thom S(2012). The efficacy and tolerability of ’polypills’: meta-analysis of randomised controlled trials. PLoS One vol. 7, Article 12, e52145-e52145.
Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS et al.(2011). Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol vol. 12, Article 1, 65-82.
Gupta AK, Nasothimiou EG, Chang CL, Sever PS, Dahlof B, Poulter NR(2011). Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens vol. 29, Article 10, 2004-13.
Gupta AK, Prieto-Merino D, Dahlof B, Sever PS, Poulter NR(2011). Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach. Diabet Med vol. 28, Article 8, 941-7.
Gupta AK, Savopoulos CG, Ahuja J, Hatzitolios AI(2011). Role of phytosterols in lipid-lowering: current perspectives. Qjm vol. 104, Article 4, 301-8.
Sever PS, Chang CL, Gupta AK, Whitehouse A, Poulter NR(2011). The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K. Eur Heart J vol. 32, Article 20, 2525-32.
Gupta AK(2011). The efficacy and cost-effectiveness of statins in low-risk patients. Cmaj vol. 183, Article 16, 1821-3.
Gupta AK, Arshad S, Poulter NR(2010). Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension vol. 55, Article 2, 399-407.
Gupta AK, Poulter NR, Dobson J, Eldridge S, Cappuccio FP, Caulfield M, Collier D, Cruickshank JK et al.(2010). Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial. Am J Hypertens vol. 23, Article 9, 1023-30.
Gupta AK, Dahlof B, Sever PS, Poulter NR(2010). Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA. Diabetes Care vol. 33, Article 7, 1647-51.
Gupta AK(2010). Racial differences in response to antihypertensive therapy: does one size fits all?. Int J Prev Med vol. 1, Article 4, 217-9.
Gupta AK, Poulter NR(2010). The concept of the metabolic syndrome is it dead yet?. J Am Coll Cardiol, vol. 56,
Gupta AK, Poulter NR, Eldridge S, Cappuccio FP, Caulfield MJ, Dobson J, Cruickshank JK, Griffiths CJ et al.(2008). Ethnic differences in blood pressure response to atenolol and amlodipine monotherapy and to add on diuretic and ACE inhibitor dual therapy in hypertensive patients from UK in ASCOT-BPLA. JOURNAL OF HUMAN HYPERTENSION vol. 22, (10) 726-727.
Gupta AK, Dahlof B, Dobson J, Sever PS, Wedel H, Poulter NR(2008). Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm and the relative influence of antihypertensive medication. Diabetes Care vol. 31, Article 5, 982-8.
Gupta AK, Poulter NR(2007). Antihypertensive-associated incident diabetes: controversy persists. Arch Intern Med, vol. 167,
Ahuja J, Gupta M, Gupta AK, Kohli K(2004). Pharmacoeconomics. Natl Med J India vol. 17, Article 2, 80-3.
Makkar RP, Arora A, Monga A, Gupta AK(2003). Alport’s syndrome with blue sclera. J Assoc Physicians India vol. 51, 510-1.
Makkar RP, Arora A, Monga A, Gupta AK, Mukhopadhyay S(2003). Burning feet syndrome. A clinical review. Aust Fam Physician vol. 32, Article 12, 1006-9.
Monga A, Makkar RP, Arora A, Mukhopadhyay S, Gupta AK(2003). Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency. Can J Infect Dis vol. 14, Article 4, 230-1.
Monga A, Arora A, Makkar RP, Gupta AK(2003). Hypertriglyceridemia-induced acute pancreatitis–treatment with heparin and insulin. Indian J Gastroenterol vol. 22, Article 3, 102-3.
Makkar RP, Mukhopadhyay S, Monga A, Arora A, Gupta AK(2003). Palmar erythema and hoarseness: an unusual clinical presentation of sarcoidosis. Med J Aust vol. 178, Article 2, 75-6.
Makkar RP, Monga A, Arora A, Mukhopadhyay S, Gupta AK(2003). Self-referral to specialists–a dodgy proposition. Int J Health Care Qual Assur Inc Leadersh Health Serv vol. 16, Article 2-3, 87-9.
Singh NP, Arora SK, Gupta A, Anuradha S, Sridhara G, Agarwal SK, Gulati P(2003). Stroke: a rare presentation of cardiac hydatidosis. Neurol India vol. 51, Article 1, 120-1.
Monga A, Arora A, Makkar RP, Gupta AK(2002). A rare site for tuberculosis. Cmaj vol. 167, Article 10, 1149-50.
Anuradha S, Agarwal SK, Singh NP, Gupta A, Chowdhury V(2002). An unusual presentation of the Papillon-Lefevre syndrome as recurrent liver abscesses. J Assoc Physicians India vol. 50, 974-6.
Anuradha S, Bansal R, Gupta A, Singh NP, Kohli R, Agarwal SK(2002). Embolisation of haemodialysis catheter. J Assoc Physicians India vol. 50, 608-9.
Makkar RP, Mukhopadhyay S, Monga A, Gupta AK(2002). Plasmodium vivax malaria presenting with severe thrombocytopenia. Braz J Infect Dis vol. 6, Article 5, 263-5.
Return to top